We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
-1.23%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$300M
AUM Growth
+$12.2M
Cap. Flow
+$19.5M
Cap. Flow %
6.5%
Top 10 Hldgs %
38.79%
Holding
113
New
9
Increased
9
Reduced
35
Closed
13

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$8.11M
2
AMGN icon
Amgen
AMGN
+$6.68M
3
CI icon
Cigna
CI
+$6.42M
4
META icon
Meta Platforms (Facebook)
META
+$5.43M
5
FLEX icon
Flex
FLEX
+$5.28M

Top Sells

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$1.81M
2
BIB icon
ProShares Ultra NASDAQ Biotechnology
BIB
+$1.76M
3
BX icon
Blackstone
BX
+$1.39M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.26M
5
IMBI
iMedia Brands, Inc. Class A Common Stock
IMBI
+$1.11M

Sector Composition

Rank Sector Weight
1 Healthcare 27.15%
2 Communication Services 17.59%
3 Technology 15.86%
4 Industrials 9.86%
5 Miscellaneous 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLEX icon
26
Flex
FLEX
$40.8B
$4.77M 1.59%
+387,254
New +$5.28M
HWM icon
27
Howmet Aerospace
HWM
$106B
$4.76M 1.58%
269,206
-8,682
-3% -$177K
DHR icon
28
Danaher
DHR
$152B
$4.53M 1.51%
52,187
-282
-0.5% -$24.7K
SYK icon
29
Stryker
SYK
$127B
$4.02M 1.34%
24,995
– –
CNI icon
30
Canadian National Railway
CNI
$76.2B
$3.93M 1.31%
53,785
-2,750
-5% -$212K
ABBV icon
31
AbbVie
ABBV
$451B
$3.44M 1.14%
36,310
– –
EOG icon
32
EOG Resources
EOG
$75.2B
$3.27M 1.09%
31,018
– –
UBA
33
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$3.05M 1.02%
158,005
-1,000
-0.6% -$19.1K
AMAT icon
34
Applied Materials
AMAT
$366B
$2.96M 0.98%
53,163
-19,567
-27% -$1.09M
XOM icon
35
ExxonMobil
XOM
$644B
$2.52M 0.84%
33,781
-200
-0.6% -$16K
DVY icon
36
iShares Select Dividend ETF
DVY
$23.8B
$2.2M 0.73%
23,175
– –
CVX icon
37
Chevron
CVX
$396B
$2.16M 0.72%
18,946
– –
GOOG icon
38
Alphabet (Google) Class C
GOOG
$4.19T
$2.08M 0.69%
40,380
-400
-1% -$22.1K
FTV icon
39
Fortive
FTV
$18B
$1.79M 0.6%
36,577
-127
-0.3% -$6.04K
ARMO
40
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
$1.74M 0.58%
+46,574
New +$1.96M
WRK
41
DELISTED
WestRock Company
WRK
$1.6M 0.53%
24,888
– –
ABT icon
42
Abbott
ABT
$195B
$1.57M 0.52%
26,250
– –
CHTR icon
43
Charter Communications
CHTR
$18.3B
$1.47M 0.49%
4,721
– –
LBRDK
44
DELISTED
Liberty Broadband Class C
LBRDK
$1.36M 0.45%
15,917
-163
-1% -$14.7K
AMZN icon
45
Amazon
AMZN
$2.87T
$1.28M 0.43%
17,700
-240
-1% -$17.2K
KKR icon
46
KKR & Co
KKR
$97.6B
$1.27M 0.42%
62,479
– –
OMC icon
47
Omnicom Group
OMC
$24.2B
$1.16M 0.39%
16,000
– –
INTU icon
48
Intuit
INTU
$97.9B
$1.07M 0.36%
6,150
– –
NFLX icon
49
Netflix
NFLX
$340B
$1.05M 0.35%
35,700
– –
FISV
50
Fiserv Inc
FISV
$28.3B
$870K 0.29%
12,200
– –
1
2
3 4

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Private Capital Advisors held 113 positions worth $300M, up 4.2% from $288M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Private Capital Advisors deployed $19.5M of net new capital in Q1 2018, opening 9 new positions and adding to 9 existing holdings. Its largest new stake was Amgen: 36,375 shares worth $6.2M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was ProShares Ultra NASDAQ Biotechnology, an estimated $1.76M trimmed.

  • Private Capital Advisors's largest Q1 2018 buy was Amgen: 36,375 shares worth $6.2M.
  • Private Capital Advisors added most to iShares Biotechnology ETF in Q1 2018, an estimated $8.11M increase.
  • Private Capital Advisors's biggest Q1 2018 reduction was ProShares Ultra NASDAQ Biotechnology, cutting an estimated $1.76M.
  • Private Capital Advisors fully exited Halliburton in Q1 2018, selling an estimated $1.81M.
  • Private Capital Advisors's ten largest holdings make up 39% of its $300M portfolio in Q1 2018.
  • Private Capital Advisors opened 9 new positions and closed 13 in Q1 2018.
  • Private Capital Advisors's portfolio value rose 4.2% quarter-over-quarter to $300M.

Based on Private Capital Advisors's 13F filing for Q1 2018, filed 18 Apr 2018.